comparemela.com

Latest Breaking News On - Michaelw kalb - Page 1 : comparemela.com

Catalyst Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer and Other Executive Promotions

Ms. Alicia Grande, Catalyst s Current CFO, to Retire at the End of 2023 Dr. Steven Miller Promoted to Executive Vice President, Chief Operating and Scientific Officer and Jeffrey Del Carmen Promoted.

Canada
United-states
America
Alicia-grande
Steven-miller
Patrickj-mcenany
Michaelw-kalb
Lambert-eaton
University-of-new-york-at-albany
Amarin-corporation
Cincor-pharma-inc
Health-canada

Catalyst Pharmaceuticals (CPRX) Announces Appointment of Michael W. Kalb as Chief Financial Officer and Other Executive Promotions

Catalyst Pharmaceuticals (CPRX) Announces Appointment of Michael W. Kalb as Chief Financial Officer and Other Executive Promotions
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Alicia-grande
Michaelw-kalb
Steven-miller
Patrickj-mcenany
Catalyst-pharmaceuticals-inc
Taro-pharmaceutical-industries-ltd
University-of-new-york-at-albany
Impel-pharmaceuticals-inc
Amarin-corporation
Group-vice
School-of-business
Cincor-pharma-inc

Form DEF 14A AMARIN CORP PLC\UK

Form DEF 14A AMARIN CORP PLC\UK
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New-york
United-states
Spain
Japan
Memorial-sloan-kettering-cancer-center
New-jersey
Germany
Puerto-rico
China
Netherlands
Seton-hall-university
Bahrain

Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update

Trudhesa® Achieved nTRx of Over 18.5K in Q1 2023; Increase of 112% vs. Q1 2022 Trudhesa Net Product Revenue in Q1 2023 Increased 149% vs. Q1 2022 to $4.4 Million Impel to Host Investor. | May 12, 2023

United-states
American
Darren-cline
Christina-tartaglia
Michaelw-kalb
Adrian-adams
Melyssa-weible
Impel-pharmaceuticals-inc
American-academy-of-neurology
Astrazeneca
Exchange-commission
Cincor-pharma-inc

Amarin: Constantly Living In Interesting Times (NASDAQ:AMRN)

Amarin (AMRN) is back in the news again, after a major price drop recently. Read more to see why I am not planning to invest in AMRN stock right now.

Sweden
Nevada
United-states
Reno
Ireland
United-kingdom
American
Alex-denner
Tom-reilly
Michaelw-kalb
Karim-mikhail
John-thero

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.